Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend
Max Healthcare Institute Limited's Board approved FY26 financial results and recommended a final dividend of ₹2 per equity share. The Board also approved the construction of a new hospital in Lucknow and the shifting of its registered office to Haryana. Re-appointment of a director and re-classification of a promoter group entity were also approved.
The recommendation of a dividend and approval for new hospital construction are positive developments. The shifting of the registered office and re-classification of a promoter group entity are significant corporate actions that may have a medium-term impact on operations and governance.
The company announced positive financial results and recommended a dividend, along with strategic growth initiatives like hospital construction and office relocation, indicating progress and future plans.
Max Healthcare Institute Limited announced the outcome of its Board of Directors meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. S.R. Batliboi & Co. LLP, the statutory auditors, issued their report with an unmodified opinion on these results.
Furthermore, the Board recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26. This dividend is subject to shareholder approval and will be paid/dispatched within 30 days of the conclusion of the upcoming Annual General Meeting (AGM).
Key decisions also included the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27. The Board approved the re-classification request from Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category, pending stock exchange approvals. Approval was also given for the construction of Phase-I of Max Super Specialty Hospital in Lucknow, with a capacity of approximately 712 beds.
Additionally, the Board approved the shifting of the company's registered office from Maharashtra to Haryana, subject to member and regulatory approvals. The re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, was also approved, contingent upon member approval at the forthcoming AGM.
The Board meeting commenced at 12:07 PM IST and concluded at 3:44 PM IST.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.